Related Experiment Videos
Circulating immune complexes in patients with mycoplasmal pneumonia
The American Review of Respiratory Disease
|October 1, 1984
Summary
Patients with mycoplasmal pneumonia show elevated circulating immune complexes (IgG-IC) and IgM rheumatoid factor (IgM-RF). Inpatient IgG-IC levels correlate with disease severity and duration, suggesting a pathogenic role.
Area of Science:
- Immunology
- Infectious Diseases
- Pulmonology
Background:
- Mycoplasmal pneumonia is a common respiratory infection.
- Immune responses, including circulating immune complexes, play a role in disease pathogenesis.
- Conglutinin-bound immune complexes (IgG-IC) and IgM rheumatoid factor (IgM-RF) are potential biomarkers.
Purpose of the Study:
- To investigate the levels of IgG-IC and IgM-RF in patients with mycoplasmal pneumonia.
- To correlate these immune complex levels with disease severity and clinical course.
- To explore the potential pathogenic role of IgG-IC in mycoplasmal pneumonia.
Main Methods:
- Studied 114 patients with mycoplasmal pneumonia (inpatients and outpatients) and 13 healthy controls.
- Measured circulating IgG-IC and IgM-RF levels.
- Utilized density gradient centrifugation for IgG-IC analysis.
Main Results:
- Patients with mycoplasmal pneumonia had significantly higher IgG-IC and IgM-RF levels than controls.
- Inpatients exhibited higher IgG-IC levels than outpatients.
- IgG-IC levels peaked 9-30 days post-onset, correlating with pronounced pulmonary changes.
- Decreased intermediate-sized IgG-IC correlated with disease improvement.
- IgM-RF levels showed no correlation with chest radiograph findings.
Conclusions:
- Elevated circulating immune complexes (IgG-IC and IgM-RF) are characteristic of mycoplasmal pneumonia.
- Inpatient IgG-IC levels are associated with disease severity and duration.
- A decrease in intermediate-sized IgG-IC may indicate disease improvement.
- IgG-IC may play a pathogenic role in mycoplasmal pneumonia.